Opinion|Videos|November 26, 2024

Implications of IPF Survival Data for Clinical Practice and Early Intervention

Key Takeaways

  • Development of therapies that halt or reverse IPF and PAH progression is a significant unmet need.
  • Improved diagnostic tools are essential for earlier detection and intervention in IPF and PAH.
SHOW MORE

Steven Nathan, MD, discusses how the data from the IPF-PRO Registry highlights the critical relationship between early diagnosis and prognosis in IPF, revealing that FVC percent predicted, oxygen use, BMI, and age are key indicators of long-term survival, underscoring the importance of early identification, and personalized treatment plans to improve patient outcomes.

  1. What are your key takeaways from this study, and how has the data enhanced our understanding of the relationship between early diagnosis and prognosis in patients with IPF?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo